Table 3.
Telephone Screening Yields Overall and by Site for Individual Testosterone Trials
| Site | No. of Screened | Eligible for SV1 | ||
|---|---|---|---|---|
| Physical Function Trial | Sexual Function Trial | Vitality Function Trial | ||
| Albert Einstein University | 3,733 | 702 (18.8%) | 1,860 (49.8%) | 2,022 (54.2%) |
| Baylor College of Medicine | 3,819 | 840 (22%) | 1,206 (31.6%) | 1,382 (36.2%) |
| Boston University | 5,113 | 1,209 (23.6%) | 2,383 (46.6%) | 2,684 (52.5%) |
| Northwestern University | 3,065 | 817 (26.7%) | 1,050 (34.3%) | 1,253 (40.9%) |
| University of Alabama, Birmingham | 3,027 | 671 (22.2%) | 1,606 (53.1%) | 1,749 (57.8%) |
| Harbor-UCLA Medical Center | 3,905 | 1,659 (42.5%) | 1,832 (46.9%) | 1,892 (48.5%) |
| University of California, San Diego | 3,758 | 1,178 (31.3%) | 2,059 (54.8%) | 2,197 (58.5%) |
| University of Florida | 3,420 | 1,515 (44.3%) | 1,884 (55.1%) | 2,166 (63.3%) |
| University of Minnesota | 6,421 | 840 (13.1%) | 2,874 (44.8%) | 3,096 (48.2%) |
| University of Pittsburgh | 5,058 | 1,389 (27.5%) | 2,363 (46.7%) | 2,517 (49.8%) |
| University of Washington | 2,657 | 827 (31.1%) | 644 (24.2%) | 849 (32.0%) |
| Yale University | 7,109 | 2,543 (35.8%) | 2,999 (42.2%) | 3,326 (45.5%) |
| Overall | 51,085 | 14,190 (27.8%) | 22,760 (44.6%) | 25,043 (49%) |